The med-tech firm also collaborated with the Medanta group of hospitals to launch Tele-ICU services in India as Medanta e-ICU project
Better insurance cover would enhance price transparency
Radhika Merchant and Anant Ambani are going to tie the knot in July 2024. Here is all you need to know about Radhika Merchant
The American pharmaceutical giant is set to introduce its obesity drug, a competitor to Nova Nordisk's Ozempic, in India as early as next year
The increase in ARPOB comes despite significant bed additions by hospitals in the past two financial years
Each new industry group will be led by a head who will frame the strategy, business plan, go-to-market, sales, domain capability, and overall customer and people experience
Noticeably, a large number of hospital chains have tapped the public markets. Some of them include Yatharth Hospital, Jupiter Life Line and Global Healthcare
The facility, which currently employs around 1,400 people, plans to partner with more hospital operators and, with it, increase its headcount to 3,500 next year, CEO Rod Hochman told Reuters
Zerodha Co-Founder and CEO Nithin Kamath on Monday disclosed that he suffered a "mild stroke" six weeks ago. "Around 6 weeks ago, I had a mild stroke out of the blue. Dad passing away, poor sleep, exhaustion, dehydration, and overworking out -- any of these could be possible reasons," he revealed in a post on X. While disclosing about his health, Kamath said he had noticed his face drooping and struggled with reading and writing. He expects full recovery in 3-6 months. "I've gone from having a big droop in the face and not being able to read or write to having a slight droop but being able to read and write more. From being absent-minded to more present-minded. So, 3 to 6 months for full recovery," he said. He further said, "I wondered why a person who's fit and takes care of himself could be affected. The doctor said you need to know when you need to shift the gears down a bit. Slightly broken, but still getting my treadmill count". Nithin, along with his brother Nikhil Kamath, .
The initial share sale of GPT Healthcare Ltd, which operates and manages mid-sized multi-specialty hospitals under the ILS Hospitals brand, received 85 per cent subscription on the second day of the offer on Friday. The Initial Public Offering (IPO) received 1,67,51,920 bids for shares against 1,97,63,327 shares on offer, as per NSE data. The category for Retail Individual Investors (RIIs) got subscribed 1.24 times, while the quota for non-institutional investors received 79 per cent subscription. The portion for Qualified Institutional Buyers (QIBs) received 19 per cent subscription. On Wednesday, GPT Healthcare Ltd said it has collected Rs 157.54 crore from anchor investors. The Rs 525 crore IPO is a combination of a fresh issue of equity shares aggregating to Rs 40 crore and an Offer For Sale (OFS) of up to 2.6 crore equity shares by private equity firm BanyanTree Growth Capital II. BanyanTree, which holds 2.6 crore shares, or 32.64 per cent stake, in Kolkata-based GPT Healthca
National Investment and Infrastructure Fund Ltd (NIIF) on Monday announced a commitment of Rs 207 crore to private equity firm Amicus Capital for supporting tech-enabled speciality manufacturing, healthcare and financial services firms. NIIF Fund of Funds-I, the first fund under its private markets business (PMF-I), has made the commitment to Amicus Capital Partners India Fund II. With a target size of USD 200 million, Amicus Capital Fund II expects to support businesses that leverage technology to scale, early in their growth journey, across sectors such as speciality manufacturing, technology & business services, healthcare, financial services and other sectors, a joint statement said. Founded in 2016, Amicus Capital is an emerging fund manager with a strong track record in the early growth segment, it said. PMF-I backs established and emerging fund managers who have demonstrated a strong track record, an institutional mindset and a commitment to follow high standards of ...
Over 23,000 beneficiaries have availed benefits under the Ayushman Bharat health insurance scheme at the AIIMS here since September 2018, with a majority of the patients seeking treatment in the departments of medical oncology followed by ophthalmology, general medicine, orthopaedics and neurosurgery. As far as complex surgeries are concerned, 730 procedures for congenital heart diseases have been performed followed by 557 total hip replacements and 148 total knee replacements under the Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY). According to data provided by the AIIMS, 5,179 beneficiaries availed benefits of the scheme under medical oncology followed by 4,275 under the department of ophthalmology, 3,169 under general medicine, 2,260 under orthopaedics and 2,223 under neurosurgery till January 24. "The AIIMS, Delhi proudly announces the successful and effective implementation of the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (ABPMJAY) scheme. AIIMS has a ...
Alaskapox virus: Also known as AKPV, the virus is transmitted from small mammals and is related to smallpox, cowpox and mpox. Its symptoms include rash, swollen lymph nodes and joint or muscle pain
The initial share-sale of Entero Healthcare Solutions got subscribed 1.53 times on the final day of subscription on Tuesday. The Rs 1,600 crore-Initial Public Offering (IPO) got bids for 1,09,49,884 shares against 71,50,100 shares on offer, as per NSE data. The category for Qualified Institutional Buyers (QIBs) got subscribed 2.28 times, while the quota for Retail Individual Investors (RIIs) received 1.33 times subscription. The portion for Non Institutional Investors received 22 per cent subscription. The IPO was a combination of fresh issue of up to Rs 1,000 crore and an Offer For Sale (OFS) of up to 47,69,475 equity shares, aggregating up to Rs 600 crore at the upper end of the price band. Price range for the offer was Rs 1,195-1,258 per share. The healthcare products distributor collected Rs 716 crore from anchor investors on February 8. Proceeds from the fresh issue will be used towards payment of debt, funding working capital requirements, pursuing inorganic growth initiat
Maharashtra Chief Minister Eknath Shinde on Monday said the Asian Development Bank will provide loan of Rs 4,000 crore to improve medical facilities in the state. The in principle approval for the first tranche of Rs 1,200 crore has been given, he added. "The Asian Development Bank has sanctioned the pending proposal of Rs 4000 crore loan to Maharashtra for creating advanced healthcare infrastructure and medical education. It has also given in-principle approval for Rs 1,200 crore in the first phase," the CMO said in a statement. It said the CM had instructed officials to start work on a 500-bed hospital in Dharashiv (formerly Osmanabad). "The ADB has suggested seven different types of improvements at administrative level as well as in medical education. It includes centre of excellence, digital medical education and health policy, e-hospital, encouragement to medical officers and staff, property management, sustainability policy, recruitment centres, decentralisation of medicine .
The initial share sale of healthcare products distributor Entero Healthcare Solutions received 10 per cent subscription on the first day of bidding on Friday. The Rs 1,600 crore-Initial Public Offering (IPO) got bids for 6,89,678 shares against 71,50,100 shares on offer, as per NSE data. The category for Retail Individual Investors (RIIs) got subscribed 45 per cent while the quota for non-institutional investors received 4 per cent subscription. The IPO is a combination of fresh issue of up to Rs 1,000 crore and an Offer For Sale (OFS) of up to 47,69,475 equity shares, aggregating up to Rs 600 crore at the upper end of the price band. Price range for the offer is Rs 1,195-1,258 a share. Entero Healthcare Solutions has collected Rs 716 crore from anchor investors. Proceeds from the fresh issue will be used towards payment of debt, funding working capital requirements, pursuing inorganic growth initiatives through acquisitions and general corporate purposes. ICICI Securities, Dam
The company's revenue from operations was seen up by 14 per cent in FY24 to Rs 4850.6 crore, compared to Rs 4,263.6 crore during the third quarter of 2022-23
Global Health, which operates hospitals under the Medanta brand, on Thursday reported a 52 per cent increase in consolidated net profit at Rs 123 crore for the third quarter ended December 2023 on the back of increased in-patient volume and improved realisation. The healthcare provider had reported a net profit of Rs 81 crore in the year-ago period. Revenue from operations rose to Rs 833 crore in the third quarter of the current fiscal from Rs 694 crore in the year-ago period, the Gurugram headquartered firm said in a regulatory filing. "In Q3 FY2024, both our matured and developing units delivered robust revenue growth of 17 and 33 per cent year-no-year respectively," Global Health Ltd Group CEO and Director Pankaj Sahni said. The growth was primarily driven by increased in-patient volume and improved realisation, he added.
Company that makes smartphone-based medical test kits will use the financing to expand business
Over 2.78 crore Ayushman Bharat cards have been created in more than 2.3 lakh health camps organised in gram panchayats and urban local bodies across the country under the ongoing Viksit Bharat Sankalp Yatra, the Health Ministry said on Tuesday. The ministry said the health camps have seen a total footfall of over 7.2 crore since the campaign began on November 15, last year. Of the 2.78 crore Ayushman Bharat cards issued, 51 lakh physical cards have been distributed, it said. Ayushman cards are being created using the Ayushman app and physical cards are being distributed to the beneficiaries. So far, 3.85 crore people have been screened for TB at the health camps, out of which 11.8 lakh were referred to higher public health facilities, the ministry said. Screening of patients for TB is carried out by screening for symptoms, sputum testing, and using NAAT machines wherever available. Cases suspected to have TB are referred to higher facilities. Under Pradhan Mantri TB Mukt Bharat .